Source: Acrofan

Codiak: ATUM Announces Leap-In Transposase Licensing Agreement with Codiak Biosciences to Support Manufacturing of Exosome-Based Therapeutics

Read full article »
Codiak's Competitors | Codiak's News | Codiak's Financials
Stay up-to-date with the latest news on Codiak
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Douglas E. Williams's photo - President & CEO of Codiak

President & CEO

Douglas E. Williams

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Codiak